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Papillary thyroid cancers (PTCs) incidence dramatically increased in the vicinity of Chernobyl. The cancer-initiating role of radiation
elsewhere is debated. Therefore, we searched for a signature distinguishing radio-induced from sporadic cancers. Using microarrays,
we compared the expression profiles of PTCs from the Chernobyl Tissue Bank (CTB, n¼12) and from French patients with no
history of exposure to ionising radiations (n¼14). We also compared the transcriptional responses of human lymphocytes to the
presumed aetiological agents initiating these tumours, g-radiation and H2O2. On a global scale, the transcriptomes of CTB and French
tumours are indistinguishable, and the transcriptional responses to g-radiation and H2O2 are similar. On a finer scale, a 118 genes
signature discriminated the g-radiation and H2O2 responses. This signature could be used to classify the tumours as CTB or French
with an error of 15–27%. Similar results were obtained with an independent signature of 13 genes involved in homologous
recombination. Although sporadic and radio-induced PTCs represent the same disease, they are distinguishable with molecular
signatures reflecting specific responses to g-radiation and H2O2. These signatures in PTCs could reflect the susceptibility profiles of
the patients, suggesting the feasibility of a radiation susceptibility test.
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An increased incidence of thyroid carcinomas in children was first
noticed in Belarus and Ukraine 4 years after the 1986 Chernobyl
accident (Baverstock et al, 1992; Kazakov et al, 1992). Increased
incidence has been observed since then in people exposed to
fallout during childhood in these regions (United Nations
Scientific Committee of the Effect of Atomic Radiation, 2000;
Mahoney et al, 2004). The aggressiveness and morphology of these
tumours (over 95% classified on the basis of their pathology as
papillary thyroid carcinomas (PTCs)) appear to be related to the
age of the patients at the time of the accident and to the lag
between the accident and diagnosis, that is, the latency of the
cancers (Williams et al, 2004).
Radiation is the only proven cause of PTC so far. Although the
cause of PTC in patients not exposed to radiation remains
uncertain, a growing body of evidence suggests that H2O2 could
play a role in the absence of radiation. Indeed, it is a potent DNA-
damaging agent produced in large amounts during thyroid
hormone synthesis (Corvilain et al, 2000). It causes DNA damage
(guanine oxidation, single- and double-strand breaks) in human
lymphocytes (Turner et al, 2003), hamster ovarian cells (Dahm-
Daphi et al, 2000; Mondello et al, 2002), and in human, dog and
sheep thyroid cells in primary culture (Chico Galdo et al, 2006).
Hydrogen peroxide is believed to destroy follicular thyroid cells in
myxoedematous endemic cretinism (Kohrle et al, 2005) and to
cause cancers in the thyroid of Tg-a1BAR mice (Ledent et al, 1997).
Lack of protective systems, peroxiredoxin or glutathione perox-
idases, in knockout mice lead to cancer (Neumann et al, 2003; Lee
et al, 2006). Transfection of an H2O2-generating system transform
epithelial cells (Chu et al, 1996). The spontaneous somatic
mutation rate in normal mice and rat thyroid cells is substantially
higher than in liver and lung cells (Corvilain et al, 1994). With a
turnover of 8.5 years in adults (Coclet et al, 1989), thyrocytes have
time to accumulate H2O2-induced DNA damages. Hydrogen
peroxide has been found to play a role in several human cancers
(Quinn et al, 2006). Thus, a number of arguments support a role of
H2O2 in the initiation of PTC, and in particular in patients not
exposed to radiation.
The vast majority of PTCs harbour either a BRAF mutation
(45%; Xing, 2005) or a RET/PTC rearrangement (35% in adults;
Nikiforov, 2002), which are generally mutually exclusive (Soares
et al, 2003). Both gene alterations result in the constitutive
activation of the RAS–RAF–MAPK signalling pathway (Kimura
et al, 2003; Soares et al, 2003). Gene-expression signatures
separating BRAF from RET/PTC tumours have been reported,
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(Frattini et al, 2004) to several thousands (Giordano et al, 2005).
Although early reports pointed at a lower BRAF mutation
frequency in Chernobyl patients, recent evidence suggests that
the BRAF mutation is associated with age and is more prevalent
among older Chernobyl patients and/or among patients with
longer latency tumours (Kumagai et al, 2004; Lima et al, 2004;
Powell et al, 2005; Rosenbaum et al, 2005). Several research teams
have reported higher frequencies of RET/PTC rearrangements in
post-Chernobyl patients (Nikiforov et al, 1997). These higher
frequencies could result from the fact that radiation induces
double-strand breaks, and thus rearrangements rather than point
mutations (Dahm-Daphi et al, 2000), or possibly to a differing
molecular profile in childhood vs adult papillary carcinomas
(Powell et al, 2005). The induction of RET/PTC rearrangements
after in vitro irradiation of immortalised thyroid cells (Caudill
et al, 2005) supports the former explanation. Whether the two
best-characterised genetic alterations found in PTC are involved in
a radiation signature remains an open question. In addition,
radiation induces other unknown alterations.
In this paper, we have compared the gene-expression profiles of
PTCs from adult French patients with no history of exposure to
radiation and from adult Ukrainian patients exposed to Chernobyl
fallout during childhood, and asked whether there is a gene-
expression signature distinguishing radiation-induced from spora-
dic cancers. Our preliminary investigation suggested the absence
of a large-scale radiation signature (Detours et al, 2005). We
extend it here by using a more recent microarray technology, by
covering more genes, by studying more patients and by establish-
ing results with a wider range of statistical methods. We confirm
that French and Chernobyl Tissue Bank (CTB) tumours have the
same overall expression profiles and have indistinguishable BRAF
and RET/PTC frequencies.
We also compared the transcriptional responses of human cells
to the two most likely aetiological agents of CTB and French
tumours; g-radiation and H2O2. The similarity of CTB and French
tumours is mirrored by the similarity of the transcriptional
responses to g-radiation and H2O2. However, subtle expression
differences are exploitable to accurately classify these tumours
according to their origin. Part of these expression differences
includes genes involved in the differential response to H2O2 and
radiation, and genes involved in homologous recombination which
suggests that different—and detectable—susceptibility profiles
lead to sporadic and radiation—induced PTC.
MATERIALS AND METHODS
Transcriptional and genetic data
Paired samples of tumoral and adjacent non-tumoral thyroid
tissues were obtained from the CTB (www.chernobyltissuebank.-
com) and from patients undergoing surgery for thyroid disease at
the Ambroise Pare Hospital (Boulogne, France). French tissues
were immediately frozen in liquid nitrogen and stored at  801C
until use. Diagnoses were made by the Department of Pathology at
the Ambroise Pare Hospital or by the International Pathology
Panel of the CTB. The protocol received approval from the Ethics
Committees of the institutions. The detail of BRAF-RET/PTC
status determination, RNA processing and microarray data
preprocessing is available in Supplementary information file S3.
Microarray data are available from the Gene Expression Omnibus
(www.ncbi.nlm.nih.gov/geo), accession number GSE3950.
Comparison of microarray platforms
Jarzab et al (2005) data were downloaded from www.genomika.pl/
thyroidcancer/PTCCancerRes.html. We used the original MAS 5.0
normalised expression levels, took the log2 of expression ratios and
averaged over patients. The probes of the two platforms could be
matched on the basis of their Entrez IDs for 4203 genes.
Unsupervised classification
Hierarchical clustering was computed with the R language function
hclust with Ward linkage. Multidimensional scaling was computed
with the R function isoMDS. Both methods were fed Pearson
correlation distances as input.
Supervised classification
Support vector machine classification was run with linear kernel
and cost¼1 using the rfe 0.2 and e1071 1.5.9 packages for R. The
generalised partial least-square (GPLS) implementation from
package gpls 1.1.0 (Ding and Gentleman, 2004) for R was run
with default parameters. Prediction analysis of microarray
(Tibshirani et al, 2002) was run with threshold values in {1.0,
1.1, 1.2, y, 3.0} using pamr 1.25 for R. The random forest
classification used default parameters from R package random-
Forest 4.5.12 (Zhang et al, 2003). Generalised partial least-square
and random forest (RF) were combined with an external genes
selection procedure focusing on the n genes with the highest
absolute t-statistics, with n in {1, 2
1,2
2, y,2
13}. We adopted the
inner/outer cross-validation scheme described in details in
Ruschhaupt et al (2004) and implemented in the package
MCRestimate 1.3.0 to prevent parameter and gene selection biases
(Ambroise and McLachlan, 2002). Note that a simpler split-sample
validation, in which samples are not recycled as in the current
cross-validation protocol, would be suboptimal here because of the
limited availability of CTB samples (Simon et al, 2003). A 13-fold
cross-validation protocol with each round including parameter
and gene selection, and classification was run. At each one of the
13 rounds, the best parameters (including signature size) were
estimated by running a nested (inner) 12-fold cross-validation for
each combination of parameters. Table 2 presents averages over 10
repetitions of the entire inner/outer cross-validation, each based
on a different random 13-fold partitions of the data. The random
error was computed by averaging the error of five runs of the
complete classification procedure on data with CTB and French
labels randomly assigned to samples. The same protocol was used
for the classification on the basis of the 118 genes g-radiation vs
H2O2 signature, except that the number of genes, n, was chosen in
{1, 5, 10, y, 118} and that the tested prediction analysis of
microarray (PAM) thresholds were in {0.1, 0.2, y, 3.0}.
Classifications on the basis of DNA repair signatures were run
without gene selection, and therefore without inner cross-
validation. The PAM threshold was set to 0.5. All P-values were
derived by running 1000 times the complete cross-validation with
CTB and French labels assigned randomly to samples and counting
how many runs produced classification error below the error
obtained on the actual data.
Derivation of the c-radiation vs H2O2 signature
We downloaded the Supplementary data set S2 of Amundson et al
(2005) from the Oncogene web site (www.nature.com/onc/
index.html). Genes with expression values differing by 1.5-fold
between the 2.5Gy g-radiation- and H2O2 (200mM)-treated TK6
cells were selected. To remove immune system-related genes, we
downloaded the gcrma-processed version of the GNF human gene
atlas (Su et al, 2004; symatlas.gnf.org), which contains expression
profiles of normal tissues in most organs. We performed an
unpaired two class Significance Analysis of Microarrays (SAM;
Tusher et al, 2001) with class no. 1 including immune system-
related tissues and white blood cells and class no. 2 including all
other tissues. We selected the 20% top-ranking genes, which were
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and H2O2 signature.
RESULTS
Expression profiles and gene alteration status of PTCs
from France and from the Chernobyl Tissue Bank
Expression profiles were determined for the tumours of 14 patients
from France with no documented history of exposure to radiation,
and 12 tumours from the Chernobyl Tissue Bank (see online
Materials and Methods). CTB tumours are papillary cancers
collected in young people who were exposed to the Chernobyl
accident ((Thomas et al, 2000), see patient information, Table 1).
There are 9 tumours of classical subtype, 4 of follicular subtype
and 1 of trabecular subtype among the 14 French PTC samples.
There are 8 classical, 3 follicular and 1 solid subtypes among the 12
CTB PTC samples. Three French and four CTB mRNA samples
(PTC6, PTC7, PTC11 and S405, S420, S422, S423) were reused from
our earlier study (Detours et al, 2005).
The mRNA expression profiles of all tumours were determined
with 12000 EST (8000 genes) cDNA microarrays using patient-
matched nontumoural adjacent tissues as controls. To assess the
quality of the data, we compared our expression ratios averaged over
samples with those of Jarzab et al (2005), who used the Affymetrix
s
platform. Pearson’s correlation measured on the B4000 genes
available and expressed in both platforms was 0.72 (Figure 1).
Tumours were screened for the presence of a RET/PTC
rearrangement and for BRAF V600E mutation (Table 1). A RET/
PTC rearrangement was found in 42% (5/12) of the CTB tumours
and in 21% (3/14) of the French tumours. The difference between
the two groups is not significant according to Fisher’s exact test.
The BRAF mutation is found in comparable proportions in French
(36%, 5/14) and CTB tumours (41%, 5/12). None of these
alterations was detected in 30% (8/26) of the tumours.
Chernobyl Tissue Bank and French PTCs have similar
overall expression profiles
We first searched for global expression differences between CTB
and French PTCs, that is, extensive differences detectable when all
the genes present on our arrays are considered. Hierarchical
Table 1 Patient information and gene alterations
Sample
ID Origin Sex
Age in
1986
Age at
operation BRAF
RET/
PTC
PTC11 FR F 22 37   
PTC14 FR M 17 32   
PTC18 FR F NA 59 +  
PTC19 FR M 54 68   +
PTC20 FR F 54 68 +  
PTC21 FR F 39 54   +
PTC22 FR F 44 60   
PTC23 FR M 17 33   
PTC25 FR F 49 60   
PTC26 FR F 36 47 +  
PTC6 FR M 24 37   
PTC7 FR F 13 29 +  
PTC8 FR M 22 36   +
PTC9 FR F 24 38 +  
S404 CTB F 1 16   
S405 CTB F 1 16   +
S409 CTB F 11 28 +  
S414 CTB F 16 33   +
S415 CTB M 12 28 +  
S418 CTB M 10 27 +  
S420 CTB F 12 28   
S422 CTB M 15 31 +  
S423 CTB F 5 22 +  
S425 CTB M 3 19   +
V519 CTB F 2 18   +
V608 CTB F 15 32   +
F¼female; FR¼France; CTB¼Chernobyl Tissue Bank; M¼male; NA¼not
available; PTC¼papillary thyroid cancer.
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Figure 2 Global expression profiles. Top panel: hierarchical clustering on
the basis of all genes. Bottom panel: multidimensional scaling on the basis of
all genes. Distances in the two dimensions space were on average distorted
by 11% compared to the actual 8000 dimensions gene space distances.
Chernobyl Tissue Bank tumours are in bold font, French tumours in italics.
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Figure 1 IRIBHM vs Jarzab et al. (2005) microarray data. Pearson
correlation between patient-averaged log2 tumour/normal ratios of the
two studies is 0.72.
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between these two classes of PTCs (Figure 2, upper panel).
Multidimensional scaling collapses the high-dimensional genes
space into two dimensions while preserving the distance relation-
ships between all pairs of samples (Figure 2, lower panel). Figure 2
confirms that French and CTB tumours have similar expression
profiles when compared on a global scale although CTB tumours
form a more compact group.
Four supervised classification algorithms find multigenes
signatures separating CTB from French PTCs
The absence of separation between CTB and French PTCs on the
basis of all genes or at the level of individual genes, does not
exclude that these tumours are distinguishable on the basis of a
subset of genes. We investigated this possibility with a supervised
classification approach (details in Materials and Methods). To
strengthen the reliability of our conclusions, all the results were
reproduced with four linear classification procedures: linear kernel
support vector machines (LKSVM), GPLS, PAMs and RF. Each one
included or was combined with a gene selection procedure, that is,
a procedure to uncover multigenes signatures including as few
genes as possible. All four approaches were tested using a rigorous
inner/outer cross-validation procedure (Materials and Methods). It
guaranteed that classification testing was performed on indepen-
dent samples not used for classifier training. The cross-validation
results are presented in Table 2A.
The best performer was GPLS. It misclassified 17% of CTB
tumours as French PTC, 7% of French PTCs as CTB, resulting in an
overall error rate of 12%. Running the same classification on data
in which the ‘CTB’ and ‘French’ labels were randomly assigned to
the 26 tumour samples led to high error rates of 45% (n¼5,
s.d.¼12%, see Materials and Methods), as expected for random
classification of slightly unbalanced classes (12 CTB and 14 French
samples). Thus, the low error rates were unlikely to result from
artefacts, including data overfitting. Figure 3 shows the 256 most
classifying genes found by GPLS/t-statistics trained on all 26
samples (corresponding genes listed in Supplementary Table S1).
The optimal signature size varied among the different cross-
validation runs from one gene to several thousands of genes, with a
median of 256 genes. Such limited stability is widespread,
including in large studies (Ein-Dor et al, 2005; Michiels et al,
2005). The three other classification procedures, LKSVM/RFE, RF/
t-test and PAM produced a global error of 15, 23 and 27%,
respectively. Thus, undirected selections of classifying genes lead
to separation CTB and French tumours.
Note that if the classification results were confined to a subtype,
the accuracy would not be as low as 15%, it would be greater than
35%—the classical subtype is the largest, representing 65% of our
tumours.
Hydrogen peroxide and c-radiation elicit similar
transcriptional responses in lymphocytes
Because hydrogen peroxide, H2O2, is produced at high levels
during thyroid hormone synthesis (Corvilain et al, 2000) and is a
well-known DNA-damaging agent, we investigated the possibility
that in the absence of an obvious external risk factor, for example
radiation, French cancers must have occurred as a result of H2O2
exposure.
Amundson et al (2005) measured with microarrays the
transcriptional responses of a B-lymphocyte cell line, TK6, to 13
stress agents. These included 10 DNA-damaging agents: H2O2,
radiation (neutron and g-rays at 2.5 and 8Gy), adriamycin,
arsenite, campothecin, CdCl2, cisplatin, methyl methanesulphonate
and UVB (280 320nm). We downloaded the expression data
published with the paper and produced the hierarchical clustering
shown in Figure 4 (see online Materials and Methods). The
responses to 200mM H2O2 and to 2.5Gy g-radiation clustered
together, that is, among 12 stress agents, including 10 DNA-
damaging agents, g-radiation at 2.5Gy elicited the transcriptional
response that was the closest to that of H2O2. We concluded that
these similar transcriptional responses reflect similar damages in
the cells.
Table 2 Error rates for supervised classification
French error CTB error Global error
(a) Classification based on all genes
GPLS 17 7 12
PAM 25 29 27
RF 33 14 23
LKSVM 25 7 15
(b) Classification based on H2O2 vs g-radiation signature
GPLS 8 21 15
PAM 25 29 27
RF 42 7 23
LKSVM 25 7 15
French error CTB error Global error P
(c) Classification based on homologous radiation signature
GPLS 17 21 19 0.0038
PAM 25 21 23 o0.001
RF 42 21 31 0.063
LKSVM 8 21 15 0.0038
CTB¼Chernobyl Tissue Bank; GPLS¼generalised partial least-square;
LKSVM¼linear kernel support vector machines; PAM¼prediction analysis of
microarray; RF¼random forest. Classification and validation procedures are
described in Materials and Methods.
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Figure 3 Top 256 most classifying genes according to GPLS/t-statistics.
Chernobyl Tissue Bank samples are in red and French samples in black in
the top colour bar. Data are ordered with two-way hierarchical clustering
for the sake of display clarity.
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classified on the basis of genes regulated differently in
c-radiation and H2O2 responses
The transcriptional responses to g-radiation and H2O2 are broadly
similar; however, some genes are expressed differently between the
two in vitro assays. We reasoned that these expression differences
may mirror subtle underlying g-radiation and H2O2 susceptibility
differences between CTB and French tumours that could be used
for classification.
We found 293 genes in the 1451 published by Amundson et al
(2005) with a fold change greater than 1.5 between the g-radiation
(2.5Gy) and the H2O2 responses (200mM). These responses were
measured in B lymphocytes, whereas our goal was to classify
thyroid tumours. Thus, we removed immune system-specific genes
from the set of 293 genes (see online Materials and Methods). This
filtering left 162 genes. Among them, 118 were spotted on our
microarrays. They are listed in Supplementary Table S2 and will be
referred to thereafter as the g-radiation vs H2O2 signature. Note
that it was derived independently of our PTC data.
Next, we applied the same four classification algorithms as
above except that only the independently selected 118 genes were
used. Error rates (Table 2B) were comparable to those obtained in
Table 2A, where the classifying genes were selected from a list of
8000. Again, all four algorithms classified the tumours with an
error rate p27%, GPLS/t-test and LKSVM/RFE being the most
accurate with an error rate of 15%. This result shows a relation
between the g-radiation vs H2O2 signature and CTB and sporadic
carcinomas distinction, which could reflect the underlying
aetiology of CTB and French tumours.
Chernobyl Tissue Bank and French tumours are accurately
classified on the basis of 13 genes involved in homologous
recombination
To focus better on which elements of the DNA-damage response
may differ between CTB and French tumours, we investigated if
genes involved in the different DNA repair mechanisms led to
accurate classification. We collected from the Human DNA Repair
Genes database (Wood et al, 2001, 2005), all the genes known to be
involved in base-excision repair, mismatch-excision repair,
nucleotide-excision repair, homologous recombination and non-
homologous end joining. The signature from each one of these five
repair mechanisms was then used to classify the CTB and French
tumours. These signatures contain few genes and were compiled
from a source curated by DNA repair experts. Therefore, we
skipped the gene selection step, which in turn alleviates the need
for time-consuming internal cross-validation. The resulting
computational gain made it tractable to run an additional
statistical control: all five classification tasks were rerun 1000
times with the CTB and French labels randomly assigned to the
tumours to estimate P-values, that is, the odds that the
classification error was as low as the one observed with the actual
data. Besides this, the classification proceeded exactly as above.
The classification error rates were high for base-excision repair,
mismatch-excision repair and nonhomologous end joining,
regardless of the algorithm (not shown). The nucleotide-excision
repair signature produced an error rate of 27% with RF, but B50%
with GPLS, PAM and LKSVM. In contrast, the homologous
recombination signature (Table 3) led to a classification below 31%
for all four procedures, below 20% for two and equal to 15% for
LKSVM (Table 2C).
The P-value for RF, 0.064, was slightly above the 0.05
significance standard. All the other P-values were highly significant
and remained below 0.02 after adjusting for the fact that five
classification tasks were being examined (using Bonferonni
correction, i.e., multiplying the P-values by 5). This suggests that
homologous recombination, which repairs double-strand breaks,
operates differently in CTB and French tumours or in the
associated normal tissues. None of the homologous recombination
signature genes are part of the 118 genes of the g-radiation vs H2O2
signature. Thus, the homologous recombination and g-radiation vs
H2O2 signatures are nonoverlapping. They are thus two different
signatures supporting a link between radiation and the CTB/
French PTC expression differences.
DISCUSSION
We compared French and CTB tumours at the level of their global
expression profiles, that is, of their overall phenotype. Hierarchical
clustering and multidimensional scaling failed to uncover a large-
scale difference between them. Note that, would such difference
exist, our preliminary study (Detours et al, 2005) would have
revealed it. Thus, the conclusion of pathologists that sporadic and
radiation-induced PTCs are the same type of lesions is supported
by expression data.
The similarity of expression profiles on a global scale, as
observed with hierarchical clustering performed on all genes, does
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Figure 4 Hierarchical clustering of transcriptional responses of the B-
lymphocyte TK6 cell line to various stress agents. Expression data are from
Amundson et al (2005). The responses to 200mMo fH 2O2 and 2.5Gy
g-radiation cluster together. Abbreviations: MMS, methyl methane-
sulphonate; TPA, 12-O-tetradecanoylphorbol 13-acetate; UVB, ultraviolet
(280 320nm). The suffixes ‘Exp1’ and ‘Exp2’ stand for replicated
experiments.
Table 3 Homologous recombination gene signature
Symbol Name
XRCC2 X-ray repair complementing defective repair in Chinese
hamster cells 2
SHFM1 Split hand/foot malformation (ectrodactyly) type 1
RAD51C RAD51 homologue C (Saccharomyces cerevisiae)
MUS81 MUS81 endonuclease
RAD51L1 RAD51-like 1 (S. cerevisiae)
RAD51 RAD51 homologue (RecA homologue, Escherichia coli)
(S. cerevisiae)
RAD50 RAD50 homologue (S. cerevisiae)
RAD54B RAD54B homologue
RAD54L RAD54-like (S. cerevisiae)
NBS1 Nijmegen breakage syndrome 1 (nibrin)
RAD52 RAD52 homologue (S. cerevisiae)
XRCC3 X-ray repair complementing defective repair in Chinese
hamster cells 3
BRCA1 Breast cancer 1, early onset
Only homologous recombination genes represented on our microarrays are listed
(see main text).
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profiles. Supervised classification is the tool of choice to evaluate
whether a group of genes can be exploited to discriminate different
classes of tumours (Allison et al, 2006). Four linear classification
algorithms assigned the tumours to the French or CTB groups with
an error ranging from 12 to 27%, and p15% for two algorithms.
These figures are typical of properly designed microarray studies
(Ntzani and Ioannidis, 2003), and compare very favourably with
histopathological diagnosis accuracy in the field of thyroid
tumours (Baloch et al, 2001; Hegedus, 2004; Clary et al, 2005).
The stability of the gene lists uncovered through supervised
classification is problematic, even in studies using hundreds of
samples (Ein-Dor et al, 2005; Michiels et al, 2005). Clearly, much
larger studies will be needed to list exactly and exhaustively the
discriminating genes, and validate them over a larger group.
Nevertheless, our results strongly suggest that such genes exist:
accurate classification of CTB and French tumours is possible on
the basis of their expression profiles.
Initial reports of a low BRAF mutation frequencies in post-
Chernobyl tumours (Nikiforova et al, 2004) and of a large impact
of BRAF on gene expression (Giordano et al, 2005) raised the
possibility of a radiation damage signature based on the
mutational status of the tumours. The frequency of BRAF V600E
mutation was similar, 38%, in our French and CTB tumours. Our
analysis does not exclude the possibility of other damage
signatures yet to be identified.
Radiation is a proven causing factor for PTC and a number of
arguments support the view that H2O2-induced damage also
contributes to initiate these tumours (see Introduction). Taking
advantage of published data on the transcriptional responses of
human lymphocytes to 13 stress agents (Amundson et al, 2005), we
investigated how similar the responses to H2O2 and g-radiation
are. We found that among 10 genotoxic agents, H2O2 at 200mM
elicits the response most similar to that of radiation at 2.5Gy. This
strengthens the argument for H2O2 as a PTC-causing agent, as this
similarity most probably mirrors a similarity of the damage
inflicted by H2O2 and radiation. This similarity is in line with the
finding that French and CTB tumours have similar global profiles.
Interestingly, Xiong et al (2005) demonstrated that the number of
chromatid breaks per cell following g-irradiation was significantly
higher in the lymphocytes of 57 PTC patients with no documented
exposure to radiation than in the lymphocytes of healthy controls.
This difference could be related to impaired homologous
recombination as the 18067T allele variant of XRCC3 was more
frequent in 134 thyroid cancer patients than in 166 healthy patients
in another study (Sturgis et al, 2005).
Transcriptional responses to H2O2 and g-radiation are similar
relatively to other responses to genotoxic agents. However, 118
genes regulated differently in response to H2O2 and radiation were
uncovered and could be used to classify CTB and French tumours
with an error as low as 15%. This is straightforward evidence that
at least some of the genes associated with these tumours are also
associated with the response to their presumed respective
aetiological agent.
Next, we investigated whether French and CTB tumours could
be classified on the basis of five signatures covering the genes
involved in the five major DNA repair mechanisms: base-excision
repair, mismatch-excision repair, nucleotide-excision repair,
homologous recombination and nonhomologous end joining
(Wood et al, 2001, 2005). The homologous recombination
signature, which shares no genes with the H2O2 vs g-radiation
signature, led to classification errors ranging from 15 to 31%. None
of the other four signatures led to accurate classification. The
specificity for the homologous recombination effect, and the good
classification of CTB and French tumours using the 118 genes
regulated differently in response to H2O2 and radiation, make
unlikely the confounding effect of age- or ethnicity-related factors.
The fact that homologous recombination is involved in double-
strand break repair fits the notion that radiation causes more
double-strand breaks than H2O2. Nevertheless, although potential
confounders are controlled for by the use of patient-matched
adjacent tissues, they are not formally ruled out in our study. This
will become possible in the future as tumours from younger
Ukrainian patients born after 1987 become available.
Thus, several independent gene-expression signatures separate
our CTB and sporadic PTCs. These subtle expression differences
between CTB and French tumours must be interpreted in light of the
fact that the tumours investigated were removed 415 years after the
Chernobyl accident. Thus, any discriminating gene-expression
signature had to be sustained over this time interval. DNA damage
resulting from radiation, however, is typically mostly repaired
within a time scale of hours. Consequently, either the reported
signatures are ‘damage signatures’, that is, they are late results, from
radiation-induced DNA damage (e.g. non- or incorrectly repaired
damage), and/or they are ‘susceptibility signatures’, that is, they
mirror radiation susceptibility factors pre-existing to the accident.
The fact that one of the signature relies on the relative response to
the two postulated causing agents (g-rays and H2O2), and that the
other relies on double-strand break repair genes, suggests that these
signatures are related to the tumour-initiating mechanisms. This
and the longlasting presence of these signatures support the
susceptibility signature model. The recent finding that different
TP53 alleles are associated with radiation exposure in adult PTC
from Russian-Ukrainian patients (Rogounovitch et al, 2006) also
supports this view. The susceptibility model, and the corollary that
radiation susceptibility varies among individuals, may partly explain
why only a minority of the population most exposed to radiation in
Ukraine and Belarus developed PTC.
Thus, we interpret our findings as evidence for different and
detectable cancer susceptibility factors underlying CTB and French
tumours, which leads to several testable predictions. Expression
ratios of tumours with respect to patient-matched adjacent tissues
were measured. Hence, we could uncover susceptibility signatures
only to the extent that they manifest themselves differently in the
cancers and their adjacent tissues. We anticipate that the direct
comparison of expression levels instead of expression ratios could
lead to a stronger signature, possibly involving more genes. In
addition, a radiation susceptibility signature could be present in
healthy cells of any type in post-Chernobyl cancer patients. This,
then, suggests the possibility of developing an expression-based in
vitro test for radiation susceptibility. Finally, large-scale studies
could uncover the genetic or epigenetic variations underlying the
phenotypic differences reported in this paper. These concepts and
approaches may apply to other types of cancers.
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